Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Capital Reinvestment Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Capital Reinvestment Ratio of 1.33x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.19 Million) in capital expenditures (CN¥17.49 Million). Check Tianjin Tianyao Pharmaceuticals Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2000–2024)
This chart tracks Tianjin Tianyao Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see 600488 cash generation efficiency.
Annual Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. See 600488 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥569.37 Million | CN¥77.74 Million | ▼ -19.7% |
| 2023 | 0.17x | CN¥783.01 Million | CN¥133.15 Million | ▼ -45.0% |
| 2022 | 0.31x | CN¥653.52 Million | CN¥202.20 Million | ▼ -73.6% |
| 2021 | 1.17x | CN¥316.89 Million | CN¥370.84 Million | ▼ -11.5% |
| 2020 | 1.32x | CN¥346.88 Million | CN¥458.51 Million | ▲ +32.3% |
| 2019 | 1.00x | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.1% |
| 2018 | 1.08x | CN¥189.27 Million | CN¥203.58 Million | ▲ +5.1% |
| 2016 | 1.02x | CN¥63.32 Million | CN¥64.78 Million | ▲ +192.3% |
| 2015 | 0.35x | CN¥129.50 Million | CN¥45.32 Million | ▲ +272.9% |
| 2014 | 0.09x | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥41.06 Million | CN¥36.29 Million | — |